Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality

Clinical trial NCT05732064 · COMPLETED

Trial details

NCT number: NCT05732064
Sponsor: Peking University First Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Cancer Perioperative Period Dexmedetomidine Esketamine Sleep Quality

Start date: 2023-05-22
Primary completion: 2025-04-20
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.